Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v11-FR | Version v3-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2019-01-09 | 2018-11-20 |
| Drug Identification Number | 02417170 | 02417170 |
| Brand name | CONSTELLA | CONSTELLA |
| Common or Proper name | CONSTELLA 290MCG CAP 30 CA | CONSTELLA 290MCG CAP 30 CA |
| Company Name | ABBVIE CORPORATION | ABBVIE CORPORATION |
| Ingredients | Linaclotide | Linaclotide |
| Strength(s) | 290MCG | 290MCG |
| Dosage form(s) | CAPSULE | CAPSULE |
| Route of administration | ORAL | ORAL |
| Packaging size | 290MCG CAP 30 | 290MCG CAP 30 |
| ATC code | A06AX | A06AX |
| ATC description | DRUGS FOR CONSTIPATION | DRUGS FOR CONSTIPATION |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2018-11-09 | 2018-11-09 |
| Estimated end date | 2018-12-20 | 2018-11-30 |
| Actual end date | 2018-12-19 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Delay with the release of new products supply for 290 mcg only. 72 & 145 mcg are available. | Delay with the release of new products supply for 290 mcg only. 72 & 145 mcg are available. |
| Health Canada comments |